Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 2/2017

01-04-2017 | Short Research Report

Appropriateness of surgical antibiotic prophylaxis for breast surgery procedures

Authors: Smeem Jaber, Crystal Rogers, Bruce Sunderland, Richard Parsons, Sarah MacKenzie, Jason Seet, Petra Czarniak

Published in: International Journal of Clinical Pharmacy | Issue 2/2017

Login to get access

Abstract

Background Guidelines for the appropriate use of antibiotic prophylaxis are provided in the Therapeutic Guidelines: Antibiotics (eTG) in Australia. Inappropriate use of antibiotics is problematic. Objective To examine adherence with therapeutic guidelines (eTG) in breast surgery and trends in non-adherence dependent on the type of breast surgery performed. Setting Major Western Australian teaching hospital. Method A retrospective cross-sectional study reviewed a random sample of 150 from 1049 eligible medical records of patients who underwent a breast surgical procedure in 2013 or 2014. Main outcome measure Adherence to the eTG. Results Antibiotic prophylaxis was prescribed for 139 (92.7%) operations. Adherence to the eTG occurred in 20 (13.3%) operations, whilst 11 (7.3%) did not adhere to any element of the eTG. Appropriate timing was the main factor not adhered to. Postoperative antibiotics were prescribed following 35 (23.3%) operations, with 32 (91.4%) administered beyond 24 h. Length of stay was significantly different (p = 0.0036) between surgical groups. There was a tendency for risk of an infection to be decreased with adherence (odds ratio: 0.23; 95% CI: 0.05, 1.07; p = 0.06). Conclusion Adherence to the eTG was low (13.3%), despite a decreased risk of SSI when guidelines were followed.
Literature
1.
go back to reference Barr S, Topps A, Barnes N, Henderson J, Hignett S, Teasdale R, et al. Infection prevention in breast implant surgery–A review of the surgical evidence, guidelines and a checklist. EJSO. 2016;42(5):591–603.CrossRefPubMed Barr S, Topps A, Barnes N, Henderson J, Hignett S, Teasdale R, et al. Infection prevention in breast implant surgery–A review of the surgical evidence, guidelines and a checklist. EJSO. 2016;42(5):591–603.CrossRefPubMed
2.
go back to reference Acuna SA, Angarita FA, Escallon J, Tawil M, Torregrosa L. Determining the use of prophylactic antibiotics in breast cancer surgeries: a survey of practice. BMC Surg. 2012;12(1):1–6.CrossRef Acuna SA, Angarita FA, Escallon J, Tawil M, Torregrosa L. Determining the use of prophylactic antibiotics in breast cancer surgeries: a survey of practice. BMC Surg. 2012;12(1):1–6.CrossRef
3.
go back to reference Bunn F, Jones DJ, Bell‐Syer S. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. The Cochrane Library. 2012. Bunn F, Jones DJ, Bell‐Syer S. Prophylactic antibiotics to prevent surgical site infection after breast cancer surgery. The Cochrane Library. 2012.
4.
go back to reference Degnim AC, Scow JS, Hoskin TL, Miller JP, Loprinzi M, Boughey JC, et al. Randomized controlled trial to reduce bacterial colonization of surgical drains after breast and axillary operations. Ann Surg. 2013;258(2):240–7.CrossRefPubMedPubMedCentral Degnim AC, Scow JS, Hoskin TL, Miller JP, Loprinzi M, Boughey JC, et al. Randomized controlled trial to reduce bacterial colonization of surgical drains after breast and axillary operations. Ann Surg. 2013;258(2):240–7.CrossRefPubMedPubMedCentral
5.
go back to reference Cabaluna ND, Uy GB, Galicia RM, Cortez SC, Yray MDS, Buckley BS. A randomized, double-blinded placebo-controlled clinical trial of the routine use of preoperative antibiotic prophylaxis in modified radical mastectomy. World J Surg. 2013;37(1):59–66.CrossRefPubMed Cabaluna ND, Uy GB, Galicia RM, Cortez SC, Yray MDS, Buckley BS. A randomized, double-blinded placebo-controlled clinical trial of the routine use of preoperative antibiotic prophylaxis in modified radical mastectomy. World J Surg. 2013;37(1):59–66.CrossRefPubMed
6.
go back to reference Habak JE, Varma S, Kiani M, Twaddle A, Emmerton LM. Prophylactic antibiotic use in breast cancer surgery patients. J Pharm Pract Res. 2013;43(2):101–4.CrossRef Habak JE, Varma S, Kiani M, Twaddle A, Emmerton LM. Prophylactic antibiotic use in breast cancer surgery patients. J Pharm Pract Res. 2013;43(2):101–4.CrossRef
7.
go back to reference Testa M, Stillo M, Giacomelli S, Scoffone S, Argentero PA, Farina EC, et al. Appropriate use of antimicrobial prophylaxis: an observational study in 21 surgical wards. BMC Surg. 2015;15(1):1.CrossRef Testa M, Stillo M, Giacomelli S, Scoffone S, Argentero PA, Farina EC, et al. Appropriate use of antimicrobial prophylaxis: an observational study in 21 surgical wards. BMC Surg. 2015;15(1):1.CrossRef
8.
go back to reference Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med. 2003;163(8):972–8.CrossRefPubMed Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med. 2003;163(8):972–8.CrossRefPubMed
9.
go back to reference Therapeutic Guidelines; Antibiotic Version 14. Melbourne: Therapeutic Guidelines Limited. ISBN 978-0-9804764-7-7. Therapeutic Guidelines; Antibiotic Version 14. Melbourne: Therapeutic Guidelines Limited. ISBN 978-0-9804764-7-7.
10.
go back to reference Landes G, Harris PG, Lemaine V, Perreault I, Sampalis JS, Brutus J-P, et al. Prevention of surgical site infection and appropriateness of antibiotic prescribing habits in plastic surgery. J Plast Reconstr Aesthet Surg. 2008;61(11):1347–56.CrossRefPubMed Landes G, Harris PG, Lemaine V, Perreault I, Sampalis JS, Brutus J-P, et al. Prevention of surgical site infection and appropriateness of antibiotic prescribing habits in plastic surgery. J Plast Reconstr Aesthet Surg. 2008;61(11):1347–56.CrossRefPubMed
Metadata
Title
Appropriateness of surgical antibiotic prophylaxis for breast surgery procedures
Authors
Smeem Jaber
Crystal Rogers
Bruce Sunderland
Richard Parsons
Sarah MacKenzie
Jason Seet
Petra Czarniak
Publication date
01-04-2017
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 2/2017
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-017-0434-6

Other articles of this Issue 2/2017

International Journal of Clinical Pharmacy 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.